- Home
- / Microbix
Microbix
Stock Price
$21.9
2024-10-29
Market Capitalization
$729.8 M
2024-10-29
Revenue
$18.6 M
FY, 2025
Microbix Summary
Company Summary
- Overview
- Microbix is a manufacturer of viral and bacterial products. It provides medicines and antigen products for ToRCH, respiratory, dengue, childhood disease, gastrointestinal disorders, and more.
- Type
- Public
- Status
- Active
- Founded
- 1988
- HQ
- Mississauga, CA | view all locations
- Website
- https://microbix.com
- Cybersecurity rating
- Sectors
Table of Contents
Key People
Mark A. Cochran, Director
Martin Marino, Chairman of the Board
Peter M. Blecher, Director
LocationsView all
1 location detected
Mississauga, ON HQ
Canada
265 Watline Ave
Microbix Financials
Summary Financials
- Revenue (Q2, 2026)
- $C3.4M
- Gross profit (Q2, 2026)
- $C2.1M
- Net income (Q2, 2026)
- ($C1.4M)
- Cash (Q2, 2026)
- $C8.1M
- EBIT (Q2, 2026)
- ($C1.3M)
- Enterprise value
- $728.4M